Predictors of Sustainability of Response With Cenobamate: Post-hoc Subset Analysis of a Phase 3, Open-Label, Study

被引：0
|
作者：
Stern, Sean [1 ]
Wechsler, Robert [2 ,3 ]
Kerr, Wesley T. [4 ]
Wade, Clarence T. [1 ]
Vossler, David G. [5 ]
Rosenfeld, William E. [6 ]
机构：
[1] SK Life Sci Inc, Paramus, NJ USA
[2] Consultants Epilepsy & Neurol, Boise, ID USA
[3] Idaho Comprehens Epilepsy Ctr, Boise, ID USA
[4] Univ Michigan, Dept Neurol, Ann Arbor, MI USA
[5] Univ Washington, Sch Med, Seattle, WA USA
[6] Comprehens Epilepsy Care Ctr Children & Adults, St Louis, MO USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000202250
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P14-1.005
引用
收藏
页数：4
相关论文
共 50 条
  • [41] A multinational, open-label, phase 2 study of ruxolitinib in Asian patients with myelofibrosis: Japanese subset analysis
    Oritani, Kenji
    Okamoto, Shinichiro
    Tauchi, Tetsuzo
    Saito, Shigeki
    Ohishi, Kohshi
    Handa, Hiroshi
    Takenaka, Katsuto
    Gopalakrishna, Prashanth
    Amagasaki, Taro
    Ito, Kazuo
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (03) : 295 - 304
  • [42] Oteseconazole for RVVC in diabetes: post-hoc analysis of safety and clinical response in phase 3 studies
    Nyirjesy, P.
    Sobel, J. D.
    Degenhardt, T.
    Weclaw, C.
    Person, K.
    Mcgaurn, S.
    Brand, S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (02) : S784 - S784
  • [43] The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - A post-hoc analysis of a Phase 3, single-arm, open-label trial
    Stefanutti, C.
    Blom, D. J.
    Averna, M. R.
    Meagher, E. A.
    Theron, H. dT.
    Marais, A. D.
    Hegele, R. A.
    Sirtori, C. R.
    Shah, P. K.
    Gaudet, D.
    Vigna, G. B.
    Sachais, B. S.
    Di Giacomo, S.
    du Plessis, A. M. E.
    Bloedon, L. T.
    Balser, J.
    Rader, D. J.
    Cuchel, M.
    ATHEROSCLEROSIS, 2015, 240 (02) : 408 - 414
  • [44] Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
    Heerspink, Hiddo J. L.
    Sattar, Naveed
    Pavo, Imre
    Haupt, Axel
    Duffin, Kevin L.
    Yang, Zhengyu
    Wiese, Russell J.
    Tuttle, Katherine R.
    Cherney, David Z. I.
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (11): : 774 - 785
  • [45] Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
    Robert, Caroline
    Ribas, Antoni
    Schachter, Jacob
    Arance, Ana
    Grob, Jean-Jacques
    Mortier, Laurent
    Daud, Adil
    Carlino, Matteo S.
    McNeil, Catriona M.
    Lotem, Michal
    Larkin, James M. G.
    Lorigan, Paul
    Neyns, Bart
    Blank, Christian U.
    Petrella, Teresa M.
    Hamid, Omid
    Su, Shu-Chih
    Krepler, Clemens
    Ibrahim, Nageatte
    Long, Georgina, V
    LANCET ONCOLOGY, 2019, 20 (09): : 1239 - 1251
  • [46] ZETOMIPZOMIB IS ASSOCIATED WITH CLINICALLY MEANINGFUL REDUCTION OF PROTEINURIA IN LN CLASS III/IV WITH OR WITHOUT CLASS V: POST-HOC ANALYSIS FROM THE OPEN-LABEL MISSION PHASE 2 STUDY
    Parikh, Samir V.
    Saxena, Amit
    Leff, Richard
    Li, Elaine
    Park, Eunmi
    Henig, Noreen R.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S96 - S96
  • [47] Deconstructing Tolerance with Clobazam: Post Hoc Analyses fro an Open-Label Extension Study
    Gidal, Barry
    Wechsler, Robert
    Sankar, Raman
    Montouris, Georgia
    White, H. Steve
    Cloyd, James
    Peng, Guangbin
    Tworek, David
    Shen, Vivienne
    Isojarvi, Jouko
    NEUROLOGY, 2016, 86
  • [48] Deconstructing tolerance with clobazam Post hoc analyses from an open-label extension study
    Gidal, Barry E.
    Wechsler, Robert T.
    Sankar, Raman
    Montouris, Georgia D.
    White, H. Steve
    Cloyd, James C.
    Kane, Mary Clare
    Peng, Guangbin
    Tworek, David M.
    Shen, Vivienne
    Isojarvi, Jouko
    NEUROLOGY, 2016, 87 (17) : 1806 - 1812
  • [49] Predictors of non-randomization with open-label lithium and divalproex yreatment in rapid cycling bipolar disorder: a post hoc analysis
    Gao, K.
    Kemp, D. E.
    Ganocy, S. J.
    Conroy, C.
    Serrano, M. B.
    Slembarski, R.
    Calabrese, J. R.
    BIPOLAR DISORDERS, 2009, 11 : 41 - 41
  • [50] Safety and Effectiveness of Long-Term Treatment with Lurasidone in Older Adults with Bipolar Depression: Post-Hoc Analysis of a 6-Month, Open-Label Study
    Forester, Brent P.
    Sajatovic, Martha
    Tsai, Joyce
    Pikalov, Andrei
    Cucchiaro, Josephine
    Loebel, Antony
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 26 (02): : 150 - 159
12345